Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page
- CheckyesterdayChange DetectedThe updates are cosmetic UI/layout changes to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRemoved the 'Helpful Links Provided by Servier (Institut de Recherches Internationales Servier) Results Summary Lay Summary' section.SummaryDifference0.6%

- Check30 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check37 days agoChange DetectedThe page now emphasizes detailed lymphoma and virus-related infections (including specific Lymphoma subtypes and viral infections) and updates to revision version 3.1.0, while removing several broader or older hematology terms and the older revision (v3.0.2).SummaryDifference3%

- Check51 days agoChange DetectedPage revision updated to v3.0.2 from v3.0.1; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or timing.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.